Association of Nadir PSA >0.5ng/Ml after Dose Escalated External Beam Radiation With Prostate Cancer-Specific Endpoints

被引：0
|
作者：
Sheth, N. [1 ,2 ]
Osborn, V. W. [1 ,2 ]
Lee, A. [1 ,2 ]
Schwartz, D. [2 ]
Schreiber, D. [2 ]
机构：
[1] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA
[2] Vet Affairs NY Harbor Healthcare Syst, Brooklyn, NY USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 99卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2017.06.1235
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2632
引用
收藏
页码：E264 / E265
页数：2
相关论文
共 50 条
  • [31] Short-term Androgen-Deprivation Therapy Improves Prostate Cancer-Specific Mortality in Intermediate-Risk Prostate Cancer Patients Undergoing Dose-Escalated External Beam Radiation Therapy
    Zumsteg, Zachary S.
    Spratt, Daniel E.
    Pei, Xin
    Yamada, Yoshiya
    Kalikstein, Abraham
    Kuk, Deborah
    Zhang, Zhigang
    Zelefsky, Michael J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 85 (04): : 1012 - 1017
  • [32] Neoadjuvant hormone therapy and external beam radiation for localized high-risk prostate cancer: The importance of PSA nadir prior to radiation
    Ludgate, CM
    Bishop, DC
    Pai, H
    Eldridge, B
    Lim, J
    Berthelet, E
    Blood, P
    Piercy, GB
    Steinhoff, G
    RADIOTHERAPY AND ONCOLOGY, 2005, 76 : S36 - S36
  • [33] Decreased PSA Nadir as a Result of Dose-Escalated Stereotactic Body Radiation for Patients With Low- and Intermediate-Risk Prostate Cancer
    Rana, Zaker
    Potters, Louis
    Lee, Lucille
    Cox, Brett
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 101 (02): : E28 - E29
  • [34] Predictors of Castration-Resistant Prostate Cancer After Dose-Escalated External Beam Radiotherapy
    Spratt, Daniel E.
    Zumsteg, Zachary S.
    Pei, Xin
    Romesser, Paul B.
    Yamada, Josh
    Kollmeier, Marisa A.
    Woo, Kaitlin
    Zhang, Zhigang
    Zelefsky, Michael J.
    PROSTATE, 2015, 75 (02): : 175 - 182
  • [35] Assessing ISUP prostate cancer grade groups in patients treated with definitive dose escalated external beam radiation
    Toby, Jonathan
    Eade, Thomas
    Hruby, George
    Kneebone, Andrew
    Aherne, Noel
    Brown, Chris
    Guo, Lesley
    Hoffmann, Matthew
    Shakespeare, Thomas P.
    RADIOTHERAPY AND ONCOLOGY, 2021, 162 : 91 - 97
  • [36] Decreased PSA nadir as a result of dose-escalated stereotactic body radiation for patients with low- and intermediate-risk prostate cancer.
    Rana, Zaker Hamid
    Potters, Louis
    Lee, Lucille
    Cox, Brett W.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [37] Neoadjuvant hormone therapy and external-beam radiation for localized high-risk prostate cancer: The importance of PSA nadir before radiation
    Ludgate, CM
    Bishop, DC
    Pai, H
    Eldridge, B
    Lim, J
    Berthelet, E
    Blood, P
    Piercy, GB
    Steinhoff, G
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (05): : 1309 - 1315
  • [38] The PSA 'bounce' phenomena after external beam radiation for clinically localized prostate cancer.
    Rosser, CJ
    Kuban, DA
    Levy, LB
    Chichakli, R
    Pollack, A
    Lee, A
    Pisters, LL
    JOURNAL OF UROLOGY, 2002, 167 (04): : 391 - 391
  • [39] Fluctuation of ≥ 0.5 NG/ML in serum PSA more than 2 years after external-beam radiotherapy predicts for biochemical failure
    Kamat, AM
    Rosser, CJ
    Levy, LB
    Chichakli, R
    Pisters, LL
    JOURNAL OF UROLOGY, 2003, 169 (04): : 458 - 458
  • [40] HIGH-RISK PROSTATE CANCER PATIENTS WITH INITIAL PSA100 NG/ML TREATED WITH EXTERNAL-BEAM RADIOTHERAPY
    Smolska-Ciszewska, B.
    Plewicki, G.
    Giglok, M.
    Behrendt, K.
    Gawkowska-Suwinska, M.
    Nowicka, E.
    Dworzecki, T.
    Dworzecka, U.
    Zajusz, A.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S382 - S382
12345